The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

Jan. 03, 2018
Applicant:

Yale University, New Haven, CT (US);

Inventors:

Tarek Fahmy, New Haven, CT (US);

Brian Horsburgh, New Canaan, CT (US);

Assignee:

Yale University, New Haven, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/21 (2006.01); A61K 9/51 (2006.01); A61K 31/4178 (2006.01); A61K 38/17 (2006.01); A61K 35/30 (2015.01); A61P 37/04 (2006.01); A61P 35/00 (2006.01); A61K 9/127 (2006.01); A61K 31/704 (2006.01); A61K 38/20 (2006.01); A61K 45/06 (2006.01); A61K 31/4439 (2006.01); A61K 35/17 (2015.01);
U.S. Cl.
CPC ...
A61K 9/5153 (2013.01); A61K 9/1271 (2013.01); A61K 9/5146 (2013.01); A61K 31/4178 (2013.01); A61K 31/4439 (2013.01); A61K 31/704 (2013.01); A61K 35/17 (2013.01); A61K 35/30 (2013.01); A61K 38/1709 (2013.01); A61K 38/208 (2013.01); A61K 38/2013 (2013.01); A61K 38/2086 (2013.01); A61K 38/217 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01);
Abstract

Nanoparticulate compositions are disclosed. The nanoparticulate compositions typically include at least one, preferably two or more, active agent(s), one of which is an immunomodulatory compound, loaded into, attached to the surface of and/or enclosed within a delivery vehicle. The delivery vehicles can be nanolipogels including a polymeric core and a lipid shell or a biodegradable polymeric nanoparticle such as a PLGA nanoparticle. Typically, at least one of the active agents is an immunomodulator that increases an immune stimulatory response or decreases an immune suppressive response. In some embodiments, the particle includes both an immunomodulator that increases an immune stimulatory response and an immunomodulator that decreases an immune suppressive response. The particles can be decorated with a targeting moiety that improves delivery to a target cell. Methods of using the compositions to enhance an immune response and treat diseases such as cancer are also disclosed.


Find Patent Forward Citations

Loading…